These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34616670)
1. Downregulated Expression of CLEC9A as Novel Biomarkers for Lung Adenocarcinoma. Miao F; Lou Z; Ji S; Wang D; Sun Y; Liu H; Yang C Front Oncol; 2021; 11():682814. PubMed ID: 34616670 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting. Jiao L; Tao Y; Ding H; Wu F; Liu Y; Li C; Li F 3 Biotech; 2024 Sep; 14(9):215. PubMed ID: 39220827 [TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
4. Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma. Li L; Li J Front Oncol; 2023; 13():1128785. PubMed ID: 36959799 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Oncogene Function of GOLPH3 and Correlated Regulatory Network in Lung Adenocarcinoma. Zhang T; Wang Y; Chen Y; Jin S; Gao Y; Zhang D; Wu Y Front Oncol; 2021; 11():669684. PubMed ID: 34497755 [TBL] [Abstract][Full Text] [Related]
7. [The Expression of RTN1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment]. Zhu S; Zu L; Xu S Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917 [TBL] [Abstract][Full Text] [Related]
8. Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma. Lin Y; An J; Zhuo X; Qiu Y; Xie W; Yao W; Yin D; Wu L; Lei D; Li C; Xie Y; Hu A; Li S Int J Gen Med; 2022; 15():4635-4647. PubMed ID: 35535142 [TBL] [Abstract][Full Text] [Related]
9. The downregulation of fibrinogen-like protein 1 inhibits the proliferation of lung adenocarcinoma via regulating Tang XY; Xiong YL; Shi AP; Sun Y; Han Q; Lv Y; Shi XG; Frattini M; Malhotra J; Zheng KF; Liu YJ; Jiang T; Ma N; Zhao JB Transl Lung Cancer Res; 2022 Mar; 11(3):404-419. PubMed ID: 35399566 [TBL] [Abstract][Full Text] [Related]
10. AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma. Feng Z; Zhang Y; He M; Han Y; Cai C; Liu S; Liu P; Chen Y; Shen H; Zeng S Cancer Cell Int; 2022 Mar; 22(1):111. PubMed ID: 35248033 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
12. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets. Liu F; Wu H J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689 [TBL] [Abstract][Full Text] [Related]
13. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Wei D; Sun D; Sirera R; Afzal MZ; Leong TL; Li X; Wang Y Transl Lung Cancer Res; 2023 Jul; 12(7):1517-1538. PubMed ID: 37577299 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma. Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related]
18. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650 [No Abstract] [Full Text] [Related]
19. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma. Gong W; Dai W; Wei H; Chen Y; Zheng Z Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224 [TBL] [Abstract][Full Text] [Related]
20. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Fang L; Yu W; Yu G; Zhong F; Ye B Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]